$AARD
Aardvark Therapeutics, Inc.
A volume-weighted average price line from the last reported earnings date through today.
About Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.
- CEO
- Dr. Tien-Li Lee M.D.
- Employees
- 40
- Headquarters
- San Diego, CA
- Sector
- Healthcare
- Industry
- Biotechnology
- Website
- aardvarktherapeutics.com
Key stats
- Market Cap
- $85.08M
- P/E Ratio
- —
- Avg Volume (3M)
- 194.78K
- EPS
- -$3.21
- Day's Range
- $5.62 – $6.47
Fundamentals as of Aug 30, 2026